Вызовы при регистрации биологически активных добавок в Европейском союзе
March 06, 2025
September 25, 2024
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
Inpharmatis Team is pleased to announce that dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI 2024 from October 8 to 10 at Milan in Italy.
We look forward to meeting you and exploring new opportunities for collaboration together with our expertise in the following areas:
- Regulatory Affairs & Market Access
- API GMP audits, EU and EAEU GMP inspection support
- Pharmacovigilance services in the CIS regions
Contact us to book a time slot for a meeting: sales@inpharmatis.com
Looking forward to meeting you in Milan!
Challenges of Food Supplement Registration in the European Union
March 06, 2025
Изменение адреса головного офиса Inpharmatis в Латвии
February 20, 2025
Address Change of Inpharmatis Head Office in Latvia
February 20, 2025
Команда Inpharmatis посетила Казахстанский Фармацевтический Форум 2025
February 14, 2025
Inpharmatis Visited the Kazakhstan Pharmaceutical Forum 2025
February 14, 2025
Влияние недавних изменений в GVP ЕАЭС
January 21, 2025
Impact of Recent Changes in EAEU GVP
January 21, 2025
Новые правила оплаты регистрации лекарственных средств и медицинских изделий в Узбекистане
December 03, 2024
New Payment Rules for Medicines and Medical Device Registration in Uzbekistan
December 03, 2024